These 3 ASX shares just fell to 52-week lows

The Australian share market may have pushed notably higher on Thursday, but not all shares managed to follow the market higher.

In fact, a number of shares fell to 52-week lows or worse during trade yesterday. Three that caught my eye are listed below. Is this a buying opportunity?

The G8 Education Ltd (ASX: GEM) share price touched a new multi-year low of $2.67 on Thursday after going ex-dividend for its 10 cents per share interim dividend. The childcare centre operator’s shares have come under heavy selling pressure over the last 12 months after it continued to report lower-than-expected occupancy levels. While favourable government funding initiatives aiming to make childcare more affordable should be a boost to the company this year, I’m sitting on the fence for now and would prefer to wait for signs of improvement before clicking the buy button.

The iSentia Group Ltd (ASX: ISD) share price fell to an all-time low of 89 cents yesterday. The media monitoring company was a market darling a few years ago but has since fallen out of favour after a series of underwhelming business decisions and results. Whilst its shares do look dirt cheap now, unfortunately I fear that iSentia could be a company in terminal decline. As a result, I would stay well clear of its shares.

The Monash IVF Group Ltd (ASX: MVF) share price tumbled to a two and a half year low of $1.16 during trade on Thursday. The fertility treatment company’s performance has been on the decline of late due to the emergence of a low-cost competitor in Australia and the loss of a high-profile doctor. Unfortunately, things aren’t expected to improve in the near-term. Management has forecast a 25% decline in full-year net profit after tax. I expect more of the same in FY 2019 when the non-compete period ends for the aforementioned doctor.

If you own any of those shares then your portfolio might need a little lift. These top growth shares could do exactly that and more if you ask me.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended G8 Education Limited, iSentia Group Ltd, and Monash IVF Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.